Become a great expert in Nuclear Medicine applied to Pediatrics and watch your professional prestige increase immediately" 

There are groups of the population that are particularly vulnerable. Children are one of them and, for this reason, more and more avenues are being explored to provide them with adequate treatment and diagnosis. One of the new paths followed to achieve this objective is Nuclear Medicine, which offers the possibility of detecting numerous pathologies with great precision and providing the corresponding solution. 

Thus, this area is one of the most demanded in medicine today, since it is an innovative discipline capable of responding to different conditions that can attack children. Thus, this Postgraduate diploma in Nuclear Medicine in Pediatrics is the best way to provide patients with new treatments, achieving a significant professional advance thanks to what has been learned in this qualification. 

Throughout this program, students will be able to delve into different aspects of this area applied to pediatric patients, such as gammagraphic studies and PET tracers, among many others. And they will achieve this thanks to TECH's innovative 100% online learning method, which focuses on practice and offers students the possibility to learn through the analysis of clinical cases.  

Pediatrics requires specialized treatments and Nuclear Medicine can offer numerous solutions. Enroll and advance professionally thanks to this qualification” 

This Postgraduate diploma in Nuclear Medicine in Pediatrics contains the most complete and up-to-date educational program on the market. Its most notable features are:

• The development of case studies presented by experts in Nuclear Medicine and Pediatrics 
• The graphic, schematic, and eminently practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice 
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection

The way to remain a relevant professional is to update your knowledge. With this Postgraduate diploma# you will achieve it"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this training program, as well as renowned specialists from leading societies and prestigious universities.

 The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training programmed to train in real situations.  

This program is designed around Problem Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the academic year. For this purpose, the student will be assisted by an innovative interactive video system created by renowned and experienced experts.   

Nuclear Medicine is the Present and the Future. Specialize and advance professionally"

Apply Nuclear Medicine to pediatrics and improve your patient's treatments"

This Postgraduate diploma in Nuclear Medicine in Pediatrics is composed of 3 modules, through which students will learn all about the application of Nuclear Medicine in pediatric patients. These are very sensitive subjects but they can improve the lives of many people, so it is an area that can bring great prestige to the professional. Therefore, completing this qualification can be a huge boost to your reputation.

This syllabus has been specially designed for you to become the leading expert in Nuclear Medicine applied to Pediatrics"  

Module 1. Nuclear Medicine in Pediatrics

1.1. Pediatric Nuclear Medicine 

1.1.1. Management of the Child in Nuclear Medicine: Information to Parents and/or Guardians, Preparation and Scheduling, Appropriate Environments 
1.1.2. Dose Optimization 
1.1.3. Sedation and Anaesthesia 
1.1.4. Physical Aspects in Pediatric Patients: Image Acquisition and Processing 

1.2. PET/PET-CT/PET-MRI in Pediatric and Young Adult Patients 

1.2.1. Protocol Optimization 
1.2.2. Indications  
1.2.3. Non-FDG Tracers 

1.3. Central Nervous System/LCR 

1.3.1. Brain Maturation Patterns 
1.3.2. Epilepsy and Vascular Disorders 
1.3.3. Brain Tumors 
1.3.4. Hydrocephalus and Cerebrospinal Fluid Fistula 

1.4. Endocrine 

1.4.1. Thyroid Pathology: Hypothyroidism, Hyperthyroidism, Thyroid Nodule 
1.4.2. Hyperinsulinism 

1.5. Cardiopulmonary 

1.5.1. Congenital Heart Disease: Shunt Right-Left, Shunt Left-Right 
1.5.2. Bronchopulmonary Pathology: Congenital and Acquired 

1.6. Gastrointestinal System 

1.6.1. Dynamic Esophagogastric Studies 
1.6.2. Gastroesophageal Reflux, Bronchopulmonary Aspiration 
1.6.3. Hepatobiliary Gammagraphy: Biliary Tract Atresia 
1.6.4. Intestinal Bleeding: Mekel's Diverticulum, Intestinal Duplication 

1.7. Nephrourology 

1.7.1. Hydronephrosis Assessment 
1.7.2. Renal Cortical Assessment: in Infections, Ectopy 
1.7.3. Vesicoureteral Reflux: Diagnosis and Monitoring 
1.7.4. Others: Renal Malformations, Renal Transplantation, Kidney Transplantation 

1.8. Osteoarticular System 

1.8.1. Benign Lesions in Pediatric Patients: Fractures, Tumors 
1.8.2. Avascular Necrosis: Perthes' Disease and Others 
1.8.3. Sympathetic - Reflex Dystrophy 
1.8.4. Low Back Pain 
1.8.5. Infection: Osteomyelitis, Spondylodiscitis 

1.9. Neuroblastoma  

1.9.1. Diagnostic Studies: Bone Scintigraphy, MIBG and other PET Radiotracers 
1.9.2. Radiometabolic Treatment: MIBG, 177Lu-DOTATATE 

1.10. Other Tumours 

1.10.1. Osteosarcoma: Diagnosis, Response Assessment and Monitoring 
1.10.2. Bone Tracers and 18F-FDG-PET/CT PET/CT Study 
1.10.3. Ewing's Disease: Diagnosis, Response Assessment and Monitoring 
1.10.4. Bone Tracers and 18F-FDG-PET/CT Study 
1.10.5. Lymphoma: 18F-FDG PET/CT in Diagnosis, Response Assessment, Monitoring 
1.10.6. Rhabdomyosarcoma and Soft Tissue Sarcomas: 18F-FDG PET/CT in Diagnosis, Response Assessment and Monitoring 

Module 2. Infection/Inflammation: Gammagraphic Studies and PET Tracers 

2.1. Osteoarticular 

2.1.1. Osteomyelitis: Previously Healthy Bone, Diabetic Patient, Spine Surgery 
2.1.2. Prosthesis: Septic vs. Aseptic Mobilization 

2.2. Cardiac  

2.2.1. Endocarditis: Native Valve, Prosthetic Valve 
2.2.2. Myocarditis: Infectious vs. Inflammatory 
2.2.3. Intracardiac Devices 

2.3. Vascular 

2.3.1. Inflammatory Vasculitis 
2.3.2. Prosthetic Graft Infection 

2.4. Encephalitis: PET-FDG Study 

2.4.1. Paraneoplastic 
2.4.2. Infectious: Patterns and Differential Diagnosis 

2.5. Fever of Unknown Origin 

2.5.1. Immunosuppressed Patients 
2.5.2. Postoperative Fever and Recurrent Sepsis 

2.6. Systemic Disease 

2.6.1. Sarcoidosis: Diagnosis, Extent and Response to Treatment  
2.6.2. Ig4-related Disease 

2.7. Other Locations 

2.7.1. Hepatorenal Polycystic Kidney Disease: Localization of the Infectious Focus 
2.7.2. Hepatobiliary: Post-surgical Patient 

2.8. Covid-19 

2.8.1. Nuclear Medicine Studies in Acute Phase: Pulmonary Inflammation, Pulmonary Thromboembolism, Oncology Patient and Covid-19 
2.8.2. Utility of Nuclear Medicine in Postcovid Pathology: Pulmonary, Systemic 
2.8.3. Organizational Changes in a Pandemic Situation 

Module 3. The Nuclear Medicine

3.1. Physical Bases of Ionizing Radiations 

3.1.1. Ionizing Radiation and Radioactive Isotopes 
3.1.2. Types of Radiation 

3.2. Biological Effects of Ionizing Radiations 

3.2.1. Classification of Effects according to: Time of Cccurrence 
3.2.2. Biological and Dose Dependent Effect 
3.2.3. Interaction of Ionizing Radiation with Matter 
3.2.4. Ionizing Radiation-Cell Interaction: Characteristics, Direct and Non-Direct Effects 
3.2.5. Radiosensitivity 
3.2.6. Adaptive Response 

3.3. Radiopharmaceuticals 

3.3.1. The Radiopharmaceutical 
3.3.2. Conventional Diagnostic Radiopharmaceuticals 
3.3.3. Radionuclide Generators 
3.3.4. Localization Mechanisms 
3.3.5. Positron Emission Tomography Radiopharmaceuticals 
3.3.6. Synthesis Scheme 
3.3.7. Metabolic Pathway Substrates 
3.3.8. Radiopharmaceuticals with Therapeutic Effect     

3.3.8.1. Characteristics that Must be Met 
3.3.8.2. Design and Approval 

3.4. Radiopharmacy 

3.4.1. Regulatory Framework  
3.4.2. Operation 
3.4.3. Quality Control  

3.5. Image Acquisition and Processing 

3.5.1. Planar Image 
3.5.2. Components 
3.5.3. Performance: Resolution and Sensitivity 
3.5.4. Acquisition Modes: Static, Dynamic, Synchronized 
3.5.5. Reconstruction 
3.5.6. Single Photon Tomography (SPECT) 
3.5.7. Acquisition 
3.5.8. Reconstruction 
3.5.9. Positron Emission Tomography (PET) 

3.5.10. Components 
3.5.11. Acquisition of Data 
3.5.12. Operating Parameters 

3.6. Quantification Techniques: Basis 

3.6.1. In Cardiology 
3.6.2. In Neurology 
3.6.3. Metabolic Parameters 
3.6.4. The Image of TC 

3.7. Image Generation 

3.7.1. Acquisition and Reconstruction Parameters 
3.7.2. Protocols and Contrast Media 
3.7.3. Head and Neck 
3.7.4. Thorax: Cardiology, Lung 
3.7.5. Abdomen: General, Liver, Renal 

3.8. The Image of RM 

3.8.1. Resonance Phenomenon 
3.8.2. Tissue Contrast: Sequence Knowledge 
3.8.3. Diffusion 
3.8.4. Paramagnetic Contrasts 

3.9. The Multimodality Image  

3.9.1. SPECT/TC 
3.9.2. PET/TC 
3.9.3. PET/RM 

3.10. Radioprotection 

3.10.1. The Radioprotection 
3.10.2. Special Situations: Pediatrics, Pregnancy and Lactation 
3.10.3. Regulatory Framework: Implementation  
3.10.4. Dosimetry 

You will be one of the most respected physicians in the service when you complete this qualification"